NEWS

News Articles

Sangamo, Novartis Make Gene Therapy Deal for Brain Disorders

July 30, 2020

(Bloomberg) — Small-cap drug developer Sangamo Therapeutics Inc. jumped after striking a deal with Novartis AG to develop gene therapies for disorders attacking the brain and central nervous system, including autism. Sangamo will get $75 million in cash and is eligible for up to $720 million in development and commercial milestones and potential royalties. Royalties…

Read More

Covington pharmaceutical company working on COVID-19 treatment

July 29, 2020

Researchers in Covington and at other large pharmaceutical companies, that are typically competitors, are setting aside their differences to form an alliance against COVID-19 to come up with a coronavirus treatment. Takeda Pharmaceuticals, which is headquartered in Japan, and employs nearly 1,100 employees at its Newton County lab, is inching toward clinical trials for plasma…

Read More

UGA Foundation commits up to $10M to drive student, faculty startups

July 29, 2020

The University of Georgia is putting big money up front for innovation in a higher education setting. On Tuesday, the school announced the UGA Foundation’s investment committee voted during a meeting in June to approve a commitment of up to $10 million for funding innovation. The funding will allow the Foundation to partner with the…

Read More

Sharecare acquires WhiteHatAI to provide health plan and provider clients with additional capabilities to ensure healthcare payment integrity

July 27, 2020

ATLANTA and CARY, N.C., July 27, 2020 /PRNewswire/ — Sharecare, the digital health company that helps people manage all their health in one place, today announced its acquisition of WhiteHatAI, an innovator in artificial intelligence (AI) healthcare payment integrity applications. Named one of the 20 Most Promising Cognitive Solution Providers in 2019 by CIO Review, WhiteHatAI’s technology works in place of or…

Read More

STEIL INTRODUCES THE CORONAVIRUS EGC EXTENSION ACT

July 24, 2020

WASHINGTON, D.C.—House Financial Services Committee member, Rep. Bryan Steil (WI-01), introduced H.R. 7661, the Coronavirus EGC Extension Act to extend the initial public offering (IPO) on-ramp for Emerging Growth Companies (EGCs) during the ongoing coronavirus pandemic. This on-ramp gives EGCs the opportunity to access public capital markets to fund critical investment and growth by granting them appropriately…

Read More

BIO’s Dr. McMurry-Heath Warns Executive Order to “Cripple Small, Innovative Companies” Working to Eradicate COVID-19

July 24, 2020

Says biopharma researchers and scientists stand ready to support real solutions that will address patient drug costs, continue lifesaving science WASHINGTON–(BUSINESS WIRE)–Dr. Michelle McMurry-Heath, the president and CEO of the Biotechnology Innovation Organization (BIO), released a statement today warning that an executive order to adopt foreign price controls on certain prescription medicines could “cripple” companies…

Read More